Oral contraceptives and thrombosis;P-piller og trombose

Ugeskrift for Laeger

Volumn 163, Issue 34, 2001, Pages 4549-4553

  Lidegaard, O ^a   Schiodt A V ^a   Poulsen, E F ^a  

^a Amtssygehuset i Herlev ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ESTROGEN; GESTAGEN; GESTODENE; LEVONORGESTREL; NORETHISTERONE; NORGESTIMATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; MORTALITY; ORAL CONTRACEPTION; RISK FACTOR; SHORT SURVEY; SURVIVAL RATE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

CONTRACEPTIVES, ORAL; CONTROLLED CLINICAL TRIALS; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MYOCARDIAL INFARCTION; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOSIS;

EID: 0035920590     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. P-piller. Generelle forhold
2. P-piller til kvinder med særlige risici
3. Thrombotic diseases in young women and the influence from oral contraceptives
4. Effect on stroke of different progestagens in low oestrogen dose oral contraceptives
5. Thromboembolic stroke in young women
6. Cerebral thrombosis and oral contraceptives. A five-year nation-wide case-control study
7. Stroke and use of low-dose oral contraceptives in young women
8. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction. Report of a case-control study
9. Myocardial infarction in users of low-dose oral contraceptives
10. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women
11. Risk of acute myocardial infarction and low-dose combined oral contraceptives
12. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study
13. Oral contraceptives and myocardial infarction: Results of the MICA case-control study
14. Oral contraceptives and acute myocardial infarction. A five-year nation-wide case-control study
15. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism
16. Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing a third-generation progestagen
17. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
18. Risk of ideopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
19. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
20. The differential risk of oral contraceptives: The impact of full exposure history
21. Population-based study of risk of venous thromboembolism associated with various oral contraceptives
22. Oral contraceptives and venous thromboembolism. A case-control study
23. Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database
24. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias
25. Oral contraceptives and venous thromboembolism. A five-year nation-wide case-control study
26. Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark 1977-95
27. Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
28. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: Analysis of General Practice Research Database
29. Risk of venous thromboembolism among users of third generation oral contracepetives compared with users of oral contraceptives with Levonorgestrel before and after 1995: Cohort and case-control analysis
30. Oral contraceptives and thrombosis